Iterum Therapeutics plc (ITRMF)
SEC filings, insider trading & institutional ownership from EDGAR.
Health CarePharmaceuticals
Institutions
5
$101.67M held
Latest filings
10-K, 10-Q, 8-K, Form 4 & 13D/G. Sourced directly from SEC EDGAR
No filings are available yet.
Top holders
13F & 13D/G · latest quarter
| Holder | Filed | Value |
|---|---|---|
| JANE STREET GROUP, LLC | Feb 12, 2026 | $96.95M |
| GEODE CAPITAL MANAGEMENT, LLC | Feb 9, 2026 | $4.14M |
| MORGAN STANLEY | May 15, 2026 | $471.0K |
| UBS Group AG | May 5, 2026 | $96.0K |
| WELLS FARGO & COMPANY/MN | Jul 8, 2026 | $3.0K |
ITRMF's filings are public. The insight is one click away.
Scrutar's AI reads every ITRMF filing and surfaces what matters. Red flags, risk shifts, disclosure quality and key relationships. Cited to the source, free with an account.
Red Flag Detection20+ forensic checks per filingRisk RadarYear-over-year changes in risk factorsFiling DNADisclosure quality scored across six dimensionsSupply Chain GraphCustomers, suppliers & competitors mapped
Analyze ITRMF filingsNo credit cardAI reports included on the free plan
Never miss a ITRMF filing.
Get an email when ITRMF files its next 8-K, Form 4, 10-K or 10-Q with the SEC. Free, no account needed.
Free foreverNo account requiredOne-click unsubscribe
Data as of Aug 30, 2026Source: SEC EDGAR.